17,850€
2,00%
Echtzeit-Aktienkurs JOHN.+JOHN.CDR CIBC REG.S
Bid:
Ask:
Echtzeit-Chart der JOHN.+JOHN.CDR CIBC REG.S Aktie
Börsenkurse JOHN.+JOHN.CDR CIBC REG.S
| Lang & Schwarz | - | - | - | - | 17,850€ | 2,00% |
| gettex | - | - | - | - | 17,850€ | 2,29% |
Fundamentaldaten der JOHN.+JOHN.CDR CIBC REG.S Aktie
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2025 [CAD] | 131,27 Mrd. | 45,41 Mrd. | 37,35 Mrd. | 1,50 | 3,75% | 11,94 | 3,37 |
| 2024 [CAD] | 121,68 Mrd. | 22,86 Mrd. | 19,27 Mrd. | 0,77 | 3,68% | 23,15 | 3,63 |
| 2023 [CAD] | 114,93 Mrd. | 20,33 Mrd. | 19,12 Mrd. | 0,73 | 1,78% | 24,59 | 3,85 |
| 2022 [CAD] | 123,70 Mrd. | 28,28 Mrd. | 23,36 Mrd. | 0,85 | - | 20,95 | 3,88 |
| 2021 [CAD] | 117,55 Mrd. | 28,56 Mrd. | 26,18 Mrd. | 0,95 | - | 18,75 | 4,11 |
| 2020 [CAD] | 110,75 Mrd. | 22,13 Mrd. | 19,74 Mrd. | 0,72 | - | 24,86 | 4,36 |
| 2019 [CAD] | 108,96 Mrd. | 22,99 Mrd. | 20,06 Mrd. | 0,73 | - | 24,55 | 4,44 |
| 2018 [CAD] | 105,68 Mrd. | 23,33 Mrd. | 19,83 Mrd. | 0,71 | - | 25,25 | 4,63 |
| 2017 [CAD] | 99,27 Mrd. | 22,94 Mrd. | 1,69 Mrd. | 0,06 | - | 302,54 | 4,96 |
| 2016 [CAD] | 95,31 Mrd. | 26,24 Mrd. | 21,91 Mrd. | 0,76 | - | 23,36 | 5,21 |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. |
Profil der JOHN.+JOHN.CDR CIBC REG.S Aktie
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.